101 related articles for article (PubMed ID: 12664577)
1. 15-lipoxygenase-1 overexpression in prostate adenocarcinoma.
Kelavkar U; Cohen C; Eling T; Badr K
Adv Exp Med Biol; 2002; 507():133-45. PubMed ID: 12664577
[No Abstract] [Full Text] [Related]
2. Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.
Kelavkar UP; Glasgow W; Olson SJ; Foster BA; Shappell SB
Neoplasia; 2004; 6(6):821-30. PubMed ID: 15720809
[TBL] [Abstract][Full Text] [Related]
3. Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging.
Kelavkar UP; Cohen C; Kamitani H; Eling TE; Badr KF
Carcinogenesis; 2000 Oct; 21(10):1777-87. PubMed ID: 11023533
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis.
Kelavkar UP; Nixon JB; Cohen C; Dillehay D; Eling TE; Badr KF
Carcinogenesis; 2001 Nov; 22(11):1765-73. PubMed ID: 11698337
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
[TBL] [Abstract][Full Text] [Related]
6. Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma.
Shappell SB; Manning S; Boeglin WE; Guan YF; Roberts RL; Davis L; Olson SJ; Jack GS; Coffey CS; Wheeler TM; Breyer MD; Brash AR
Neoplasia; 2001; 3(4):287-303. PubMed ID: 11571629
[TBL] [Abstract][Full Text] [Related]
7. Lipoxygenase-5 is overexpressed in prostate adenocarcinoma.
Gupta S; Srivastava M; Ahmad N; Sakamoto K; Bostwick DG; Mukhtar H
Cancer; 2001 Feb; 91(4):737-43. PubMed ID: 11241241
[TBL] [Abstract][Full Text] [Related]
8. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells.
Tang S; Bhatia B; Maldonado CJ; Yang P; Newman RA; Liu J; Chandra D; Traag J; Klein RD; Fischer SM; Chopra D; Shen J; Zhau HE; Chung LW; Tang DG
J Biol Chem; 2002 May; 277(18):16189-201. PubMed ID: 11839751
[TBL] [Abstract][Full Text] [Related]
9. The use of nested RT-PCR of prostate-specific membrane antigen in blood cells: implications for the detection of haematogenous neoplastic cells in patients with prostate adenocarcinoma.
Lucotte G; Mercier G; Burckel A
Mol Cell Probes; 1998 Dec; 12(6):421-5. PubMed ID: 9843660
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a 15-lipoxygenase in human breast carcinoma BT-20 cells: stimulation of 13-HODE formation by TGF alpha/EGF.
Reddy N; Everhart A; Eling T; Glasgow W
Biochem Biophys Res Commun; 1997 Feb; 231(1):111-6. PubMed ID: 9070230
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of Cdc6, a cell cycle regulatory gene, in prostate cancer.
Robles LD; Frost AR; Davila M; Hutson AD; Grizzle WE; Chakrabarti R
J Biol Chem; 2002 Jul; 277(28):25431-8. PubMed ID: 12006585
[TBL] [Abstract][Full Text] [Related]
12. Investigation of a second 15S-lipoxygenase in humans and its expression in epithelial tissues.
Brash AR; Jisaka M; Boeglin WE; Chang MS; Keeney DS; Nanney LB; Kasper S; Matusik RJ; Olson SJ; Shappell SB
Adv Exp Med Biol; 1999; 469():83-9. PubMed ID: 10667314
[No Abstract] [Full Text] [Related]
13. Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells.
Angelucci A; Garofalo S; Speca S; Bovadilla A; Gravina GL; Muzi P; Vicentini C; Bologna M
Endocr Relat Cancer; 2008 Mar; 15(1):91-100. PubMed ID: 18310278
[TBL] [Abstract][Full Text] [Related]
14. Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.
Olsson M; Gustafsson O; Skogastierna C; Tolf A; Rietz BD; Morfin R; Rane A; Ekström L
Prostate; 2007 Sep; 67(13):1439-46. PubMed ID: 17639508
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a second 15S-lipoxygenase in humans.
Brash AR; Boeglin WE; Chang MS
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6148-52. PubMed ID: 9177185
[TBL] [Abstract][Full Text] [Related]
16. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
[TBL] [Abstract][Full Text] [Related]
17. 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma.
Shappell SB; Boeglin WE; Olson SJ; Kasper S; Brash AR
Am J Pathol; 1999 Jul; 155(1):235-45. PubMed ID: 10393855
[TBL] [Abstract][Full Text] [Related]
18. Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase.
Moretti RM; Montagnani Marelli M; Sala A; Motta M; Limonta P
Int J Cancer; 2004 Oct; 112(1):87-93. PubMed ID: 15305379
[TBL] [Abstract][Full Text] [Related]
19. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
[TBL] [Abstract][Full Text] [Related]
20. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.
Jiang Z; Wu CL; Woda BA; Iczkowski KA; Chu PG; Tretiakova MS; Young RH; Weiss LM; Blute RD; Brendler CB; Krausz T; Xu JC; Rock KL; Amin MB; Yang XJ
Histopathology; 2004 Sep; 45(3):218-25. PubMed ID: 15330799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
